Stock listing

Hamburg:12X1 Anavex Life Sciences Corp. Aktie

German listing (Hamburg) of Anavex Life Sciences Corp. · home listing NASDAQ:AVXL

Follow Anavex Life Sciences Corp. into a list and get an email when it puts out news.

Home listing price · NASDAQ:AVXL

$0.592 USD -0.128 (-17.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:AVXL

Past year -81.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.590 – $0.710 USDNov 20, 2026
Volume
1.64M sharesNov 20, 2026
Market cap
$54.83M USDAt the close on Nov 20, 2026 · price × 92.70M shares outstanding
52-week range
$0.590 – $5.360 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.97M USDMedian day 1.02M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Anavex Life Sciences Corp. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:AVXL · Home$0.592 USD-0.128 (-17.8%)1,635,526$0.668$0.710$0.590$0.719Close on Nov 20, 2026
LSE:0HFR$0.624 USD-0.044 (-6.5%)10,821$0.668$0.704$0.619$0.667Close on Nov 20, 2026
Frankfurt:12X1€0.478 EUR-0.040 (-7.7%)—€0.492€0.492€0.478€0.517Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AVXL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.592-0.128-17.8%$0.668$0.710$0.5901,635,526
$0.719-0.021-2.8%$0.739$0.780$0.7151,056,954
$0.740-0.078-9.5%$0.830$0.840$0.7082,251,523
$0.818-0.116-12.4%$0.940$0.950$0.8002,724,279
$0.934-0.056-5.6%$1.000$1.000$0.9171,289,418
$0.989-0.071-6.7%$1.050$1.055$0.9801,249,634
$1.060-0.070-6.2%$1.130$1.140$1.050903,524
$1.130-0.090-7.4%$1.200$1.230$1.120582,761
$1.220+0.070+6.1%$1.160$1.255$1.1301,041,397
$1.150+0.040+3.6%$1.120$1.150$1.0951,053,819
$1.110-0.150-11.9%$1.260$1.260$1.0651,566,943
$1.260+0.060+5.0%$1.240$1.285$1.220927,736
$1.200+0.060+5.3%$1.150$1.250$1.145813,287
$1.140-0.050-4.2%$1.180$1.200$1.1301,110,975
$1.190-0.110-8.5%$1.300$1.300$1.1801,195,922
$1.3000.0000.0%$1.310$1.320$1.270898,175
$1.300-0.010-0.8%$1.300$1.305$1.2451,024,843
$1.310+0.030+2.3%$1.260$1.315$1.2501,350,722
$1.280-0.050-3.8%$1.310$1.310$1.255912,370
$1.330-0.030-2.2%$1.340$1.349$1.290626,212
$1.3600.0000.0%$1.330$1.405$1.3301,015,000
$1.3600.0000.0%$1.400$1.400$1.3101,052,500
$1.360+0.110+8.8%$1.250$1.400$1.2251,672,700
$1.250-0.060-4.6%$1.300$1.310$1.1401,873,900
$1.310-0.170-11.5%$1.470$1.470$1.3001,469,900
$1.480-0.010-0.7%$1.500$1.540$1.4701,768,400
$1.490+0.010+0.7%$1.450$1.550$1.4501,226,100
$1.480-0.030-2.0%$1.530$1.530$1.4751,194,600
$1.510+0.020+1.3%$1.470$1.540$1.4451,192,700
$1.490-0.050-3.2%$1.540$1.540$1.4401,286,100
$1.540+0.010+0.7%$1.530$1.580$1.5001,467,300
$1.530-0.070-4.4%$1.570$1.610$1.5151,334,700
$1.600-0.045-2.7%$1.660$1.710$1.5601,434,500
$1.645-0.175-9.6%$1.790$1.815$1.6302,024,100
$1.820-0.070-3.7%$1.880$1.880$1.7201,989,000
$1.890-0.130-6.4%$2.000$2.010$1.8802,342,800
$2.020-0.340-14.4%$2.380$2.380$1.8902,957,900
$2.360+0.010+0.4%$2.350$2.415$2.3101,756,100
$2.350-0.030-1.3%$2.420$2.431$2.350522,500
$2.380+0.040+1.7%$2.350$2.430$2.320744,400
$2.340-0.010-0.4%$2.330$2.370$2.270937,100
$2.350-0.120-4.9%$2.470$2.490$2.305778,900
$2.470+0.070+2.9%$2.410$2.485$2.390639,900
$2.400-0.020-0.8%$2.420$2.420$2.350574,500
$2.420+0.010+0.4%$2.420$2.450$2.380920,500
$2.410+0.050+2.1%$2.410$2.480$2.405364,700
$2.360-0.080-3.3%$2.440$2.470$2.310906,000
$2.440-0.160-6.2%$2.590$2.590$2.430945,200
$2.600-0.020-0.8%$2.610$2.640$2.550657,900
$2.620-0.040-1.5%$2.710$2.737$2.610624,300
$2.660-0.090-3.3%$2.710$2.735$2.615433,600
$2.750-0.100-3.5%$2.840$2.895$2.740438,500
$2.850-0.010-0.3%$2.810$2.880$2.770559,100
$2.860+0.010+0.4%$2.820$2.905$2.810307,100
$2.850-0.040-1.4%$2.900$2.940$2.820421,900
$2.890+0.020+0.7%$2.880$2.978$2.815587,400
$2.870+0.070+2.5%$2.790$2.900$2.755826,600
$2.800-0.190-6.4%$2.950$2.970$2.7801,033,700
$2.990-0.140-4.5%$3.120$3.130$2.960893,400
$3.130-0.110-3.4%$3.248$3.260$3.120652,700
$3.240-0.320-9.0%$3.500$3.540$3.2201,180,200
$3.560+0.450+14.5%$3.370$3.680$3.3652,474,400
$3.110-0.130-4.0%$3.220$3.225$3.090457,100
$3.240+0.110+3.5%$3.170$3.290$3.160480,800
$3.130-0.260-7.7%$3.340$3.360$3.090556,900

Splits

1 split · NASDAQ:AVXL · every price before a split is adjusted for it

DayRatioWhat
1-for-4Consolidation
Ticker
Hamburg:12X1
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Hamburg
Currency
EUR

What changed lately

Latest news

All Anavex Life Sciences Corp. news

Anavex Life Sciences Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
37 in the last 12 months · 244 in all · newest Nov 3, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Feb 9, 2026
Decks
35 decks · latest September 2026

Where Anavex Life Sciences Corp. is listed

ListingExchangeCountryCurrency
NASDAQ:AVXL · Home listingNASDAQUnited StatesUSD
gettex:12X1gettexGermanyEUR
LS Exchange:A1411SLS ExchangeGermanyEUR
Lang & Schwarz:A1411SLang & SchwarzGermanyEUR
LSE:0HFRLSEUnited KingdomUSD
Tradegate:12X1TradegateGermanyEUR
BOATS:AVXLBOATSUnited StatesUSD
BX Swiss:12X1BX SwissSwitzerlandCHF
Dusseldorf:12X1DusseldorfGermanyEUR
Frankfurt:12X1FrankfurtGermanyEUR
Hamburg:12X1 · This pageHamburgGermanyEUR
Munich:12X1MunichGermanyEUR
Stuttgart:12X1StuttgartGermanyEUR

Valuation

Price/book 0.5× against a median of 1.9×: the lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
−$63.50M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
2.39

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Anavex Life Sciences Corp. · NASDAQ:AVXLUS$54.83M−US$63.50Mn/an/an/a0.5×n/a0.0×2.39
Kazia Therapeutics Ltd · NASDAQ:KZIAUS$56.22MUS$10.31Mn/a371×n/a1.8×n/a0.0×2.31
OKYO Pharma Limited · NASDAQ:OKYOUS$56.15MUS$35.56Mn/an/an/a4.5×n/a0.0×1.02
Gwo Xi Stem Cell Applied Technology Co., Ltd. · TPEX:6704US$55.78MUS$51.66Mn/a9.1×n/a2.5×−43.0%0.3×n/a
Cognition Therapeutics, Inc. · NASDAQ:CGTXUS$55.37MUS$25.10Mn/an/an/a1.9×n/a0.0×2.28
EyeGene, Inc. · KRX:185490US$55.25MUS$26.51Mn/a8.0×n/a1.5×−391.5%0.0×n/a
AB Science SA · EURONEXT:ABUS$55.19MUS$50.53Mn/a39.2×n/an/a−132.6%n/an/a
Azora Therapeutics, Inc. · NASDAQ:AZRUS$55.00MUS$33.00Mn/an/an/an/an/an/a1.00
Island Pharmaceuticals Ltd · ASX:ILAUS$54.90MUS$46.37Mn/a248×n/a6.2×n/a0.0×n/a
Nordicus Partners Corp · OTC:NORDUS$54.44MUS$54.44Mn/an/an/a0.9×n/a0.0×0.45
Boundless Bio, Inc. · NASDAQ:BOLDUS$53.61M−US$9.28Mn/an/an/a0.9×n/a0.0×0.65
Median of the othersUS$55.22MUS$34.28M39.2×1.9×−132.6%0.0×1.01

Forecasts

1 strong buy · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
20.00 USD · Analysts' mean
EPS, year to Sep 2026
-0.33 · 1 analyst

Team and board

Officers

OfficerRole
Terrie KellmeyerDirector, President, and Chief Executive Officer
Daniel KlamerVice President of Business Development and Scientific Strategy
Wolfgang LiedtkeSenior Vice President, Global Head of Neurology
Sandra BoenischPrincipal Financial Officer

Board

DirectorRole
Axel PaegerIndependent Director
Claus van der VeldenIndependent Director
Peter DonhauserMember of the Board of Directors
Terrie KellmeyerDirector, President, and Chief Executive Officer

Events

Next results
Nov 24, 2026 (expected)

Calls

CallWhenStatus
Anavex Life Sciences (NASDAQ:AVXL) Q1 2026 Earnings CallMon, Feb 09, 2026 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q4 2025 Earnings CallTue, Nov 25, 2025 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q3 2025 Earnings CallTue, Aug 12, 2025 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q2 2025 Earnings CallTue, May 13, 2025 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q1 2025 Earnings CallWed, Feb 12, 2025 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q4 2024 Earnings CallMon, Dec 23, 2024 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q3 2024 Earnings CallTue, Aug 06, 2024 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q2 2024 Earnings CallThu, May 09, 2024 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q1 2024 Earnings CallWed, Feb 07, 2024 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q4 2023 Earnings CallMon, Nov 27, 2023 · 8:30 AM ETReplay
All 25 calls
CallWhenStatus
Anavex Life Sciences (NASDAQ:AVXL) Q3 2023 Earnings CallTue, Aug 08, 2023 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q2 2023 Earnings CallTue, May 09, 2023 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q1 2023 Earnings CallTue, Feb 07, 2023 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q4 2022 Earnings CallMon, Nov 28, 2022 · 8:30 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q3 2022 Earnings CallTue, Aug 09, 2022 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q2 2022 Earnings CallTue, May 10, 2022 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q1 2022 Earnings CallWed, Feb 09, 2022 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q4 2021 Earnings CallSun, Nov 14, 2021 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q3 2021 Earnings CallThu, Aug 12, 2021 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q2 2021 Earnings CallThu, May 13, 2021 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q1 2021 Earnings CallThu, Feb 11, 2021 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q4 2020 Earnings CallMon, Dec 28, 2020 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q3 2020 Earnings CallThu, Aug 06, 2020 · 11:00 AM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q2 2020 Earnings CallThu, May 07, 2020 · 4:30 PM ETReplay
Anavex Life Sciences (NASDAQ:AVXL) Q1 2020 Earnings CallThu, Feb 06, 2020 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Aug 25, 2026 · Before open+14.5%
Q2 2026Jun 30, 2026−0.8%
Q1 2026Feb 9, 2026 · Before open+6.1%
Q4 2025Nov 25, 2025+25.3%
Q3 2025Aug 12, 2025 · Before open−5.0%
Q2 2025May 13, 2025 · Before open−5.0%
Q1 2025Feb 12, 2025 · Before open+5.0%
Q4 2024Nov 25, 2024 · Before open+0.2%
Q3 2024Aug 6, 2024 · Before open+5.7%
Q2 2024May 9, 2024 · Before open+4.6%
All 20 quarters
QuarterResultsShare move
Q1 2024Feb 7, 2024 · Before open−3.5%
Q4 2023Nov 27, 2023 · Before open−10.0%
Q3 2023Aug 8, 2023 · Before open+4.6%
Q2 2023May 9, 2023 · After close+3.2%
Q1 2023Feb 7, 2023 · Before open+5.8%
Q4 2022Nov 28, 2022 · Before open−23.5%
Q3 2022Aug 9, 2022 · Before open−5.7%
Q2 2022May 10, 2022 · Before open+1.3%
Q1 2022Feb 9, 2022 · Before open+5.8%
Q4 2021Nov 24, 2021 · Before open+5.7%

Open Events

Decks

DeckKindSlidesDate
Proxy Contest (September 2026)Proxy contest25 slidesSeptember 2026
AD/PD 2026, CopenhagenConference27 slidesMar 21, 2026
Investor Presentation (February 2026)Investor deck37 slidesFebruary 2026
Investor Presentation (January 2026)Investor deck37 slidesJanuary 2026
Technical Presentation (February 2022)Technical24 slidesFeb 2, 2022
Investor Presentation (September 2021)Investor deck43 slidesSep 13, 2021
Investor Presentation (August 2021)Investor deck43 slidesAugust 2021
Investor Presentation (July 2021)Investor deck43 slidesJuly 2021
Investor Presentation (April 2021)Investor deck37 slidesApril 2021
Investor Presentation (February 2021)Investor deck30 slidesFebruary 2021
All 35 decks
DeckKindSlidesDate
Investor Presentation (January 2021)Investor deck31 slidesJanuary 2021
CTAD 2020Conference33 slidesNov 6, 2020
Investor Presentation (November 2020)Investor deck29 slidesNovember 2020
Investor Presentation (June 2020)Investor deck27 slidesJune 2020
Investor Presentation (February 2020)Investor deck28 slidesFebruary 2020
CTAD 2019Conference17 slidesDecember 2019
Investor Presentation (October 2019)Investor deck38 slidesOctober 2019
Investor Presentation (April 2019)Investor deck29 slidesApril 2019
Investor Presentation (March 2019)Investor deck29 slidesMarch 2019
CTAD 2018Conference28 slidesOctober 2018
Investor Presentation (May 2018)Investor deck61 slidesMay 2018
Investor Presentation (March 2018)Investor deck57 slidesMarch 2018
Investor Presentation (June 2017)Investor deck51 slidesJune 2017
Investor Presentation (2016)Investor deck33 slidesJun 15, 2016
2016 Rett Syndrome SymposiumConference30 slidesJune 2016
Investor Presentation (2016)Investor deck38 slidesMar 27, 2016
Conference Presentation (March 2016)Conference27 slidesMar 12, 2016
2016 Epilepsy Pipeline ConferenceConference19 slidesFeb 26, 2016
CTAD 2015Conference18 slidesNov 7, 2015
Investor Presentation (2015)Investor deck32 slidesNov 6, 2015
Investor Presentation (May 2015)Investor deck34 slidesMay 2015
Investor Presentation (January 2015)Investor deck29 slidesJan 6, 2015
Investor Presentation (2014)Investor deck27 slidesJul 13, 2014
Investor Presentation (November 2013)Investor deck14 slidesNov 12, 2013
BIO CEO Conference 2012Conference25 slidesFeb 14, 2012

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Research and development37.6M41.8M43.7M37.9M33.0M25.2M22.3M13.3M10.7M7.25M
Selling, general and administrative13.8M11.0M12.0M
Operating income-51.4M-52.9M-55.8M-51.0M-42.0M-31.1M
Depreciation and amortization1.25K
Income before tax-46.4M-43.0M-47.5M-47.6M-37.6M-26.3M-26.2M-17.2M-13.4M-14.7M
Net income-46.4M-43.0M-47.5M-48.0M-37.9M-26.3M-26.3M-17.3M-13.5M-14.7M
Earnings per share, basic-0.54-0.52-0.60-0.62-0.54-0.45-0.54-0.39-0.33-0.42
Earnings per share, diluted-0.54-0.52-0.60-0.62-0.54-0.45-0.54-0.39-0.33-0.42

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents102.6M132.2M151.0M149.2M152.1M29.2M22.2M22.9M27.4M9.19M
Current assets25.3M26.1M27.8M9.45M
Total assets103.8M135.6M154.4M152.7M161.6M34.5M25.3M26.2M27.8M9.50M
Accounts payable4.25M9.63M4.32M3.83M4.74M3.99M3.52M2.96M
Current liabilities10.8M7.31M5.04M3.88M3.58M3.19M
Total liabilities8.95M15.3M12.5M10.2M10.8M7.31M5.04M3.58M3.19M
Shareholders' equity94.9M120.3M141.9M142.5M150.8M27.2M20.3M22.3M25.9M6.31M
Shares outstanding86.7M84.8M82.1M77.9M75.9M62.0M52.7M45.9M43.3M36.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-39.0M-30.8M-27.8M-24.2M-30.4M-21.3M-18.5M-12.6M-9.02M-9.24M
Cash from financing9.43M12.0M29.7M21.3M153.2M28.4M17.8M8.07M27.3M3.13M
Change in cash-29.6M-18.8M1.87M-2.95M122.9M7.06M-745.0K

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
8-K · Current reportNov 3, 2026Management or board changeSEC
8-K · Current reportNov 2, 2026Management or board changeSEC
8-K · Current reportOct 20, 2026Current reportSEC
8-K · Current reportOct 15, 2026Current reportSEC
3 · Initial statement of ownershipOct 5, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 5, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 28, 2026Insider tradeSEC
8-K · Current reportSep 28, 2026Meeting outcomeSEC
DFAN14ASep 18, 2026Other filingsSEC
DFAN14ASep 18, 2026Other filingsSEC
DFAN14ASep 17, 2026Other filingsSEC
DEFA14A · Additional proxy materialSep 15, 2026Meeting noticeSEC
DFAN14ASep 15, 2026Other filingsSEC
DEFA14A · Additional proxy materialSep 14, 2026Meeting noticeSEC
DFAN14ASep 10, 2026Other filingsSEC
DFAN14ASep 9, 2026Other filingsSEC
DFAN14ASep 9, 2026Other filingsSEC
8-K · Current reportSep 9, 2026Current reportSEC
DEFA14A · Additional proxy materialSep 8, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 4, 2026Meeting noticeSEC
DFAN14ASep 3, 2026Other filingsSEC
DFAN14ASep 2, 2026Other filingsSEC
8-K · Current reportSep 2, 2026Current reportSEC
DFAN14ASep 2, 2026Other filingsSEC
DEFA14A · Additional proxy materialSep 1, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 31, 2026Meeting noticeSEC
10-Q · Quarterly reportAug 28, 2026Quarterly reportSEC
10-Q · Quarterly reportAug 28, 2026Quarterly reportSEC
10-Q/A · Quarterly report, amendedAug 28, 2026Quarterly reportSEC
10-K/A · Annual report, amendedAug 28, 2026Annual reportSEC
DEFC14AAug 27, 2026Other filingsSEC
PRRN14AAug 26, 2026Other filingsSEC
8-K · Current reportAug 25, 2026ResultsSEC
DEFA14A · Additional proxy materialAug 24, 2026Meeting noticeSEC
DFAN14AAug 19, 2026Other filingsSEC
PRRN14AAug 17, 2026Other filingsSEC
DEFA14A · Additional proxy materialAug 17, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 17, 2026Meeting noticeSEC
8-K · Current reportAug 17, 2026Current reportSEC
DEFA14A · Additional proxy materialAug 11, 2026Meeting noticeSEC
8-K · Current reportAug 11, 2026Current reportSEC
DEFC14AAug 11, 2026Other filingsSEC
NT 10-Q · Late filing noticeAug 10, 2026Explanation requestSEC
8-K · Current reportAug 3, 2026Current reportSEC
PREC14AJul 31, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeJul 31, 2026Big-stake noticeSEC
8-K · Current reportJul 30, 2026ResultsSEC
PREC14AJul 24, 2026Other filingsSEC
8-K · Current reportJul 20, 2026Current reportSEC
8-K · Current reportJun 26, 2026Current reportSEC
8-K · Current reportMay 22, 2026Current reportSEC
8-K · Current reportMay 15, 2026Management or board changeSEC
3 · Initial statement of ownershipMay 14, 2026Insider tradeSEC
NT 10-Q · Late filing noticeMay 11, 2026Explanation requestSEC
8-K · Current reportMay 6, 2026Management or board changeSEC
3 · Initial statement of ownershipMay 1, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
8-K · Current reportMar 25, 2026Current reportSEC
8-K · Current reportFeb 25, 2026Management or board changeSEC
10-Q · Quarterly reportFeb 9, 2026Quarterly reportSEC
8-K · Current reportFeb 9, 2026ResultsSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
10-K · Annual reportNov 25, 2025Annual reportSEC
8-K · Current reportNov 25, 2025ResultsSEC
8-K · Current reportNov 14, 2025Current reportSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
10-Q · Quarterly reportAug 12, 2025Quarterly reportSEC
8-K · Current reportJul 25, 2025Material contractSEC
424B5 · ProspectusJul 25, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 24, 2025Other filingsSEC
CORRESP · Letter to the SECJul 21, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 21, 2025Other filingsSEC
S-3 · Registration statementJul 14, 2025Offer documentSEC
8-K · Current reportJul 3, 2025Management or board changeSEC
8-K · Current reportJun 13, 2025Management or board changeSEC
4 · Change in ownershipJun 9, 2025Insider tradeSEC
10-Q · Quarterly reportMay 13, 2025Quarterly reportSEC
4 · Change in ownershipApr 30, 2025Insider tradeSEC
4 · Change in ownershipApr 30, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 25, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 25, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 25, 2025Meeting noticeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipMar 26, 2025Insider tradeSEC
10-Q · Quarterly reportFeb 12, 2025Quarterly reportSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipDec 23, 2024Insider tradeSEC
4 · Change in ownershipDec 23, 2024Insider tradeSEC
10-K · Annual reportDec 23, 2024Annual reportSEC
4 · Change in ownershipDec 6, 2024Insider tradeSEC
4 · Change in ownershipDec 6, 2024Insider tradeSEC
10-Q · Quarterly reportAug 6, 2024Quarterly reportSEC
8-K · Current reportJul 30, 2024Current reportSEC
S-3 · Registration statementJul 29, 2024Offer documentSEC
8-K · Current reportJun 21, 2024Meeting outcomeSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 9, 2024ResultsSEC
DEFA14A · Additional proxy materialMay 6, 2024Meeting noticeSEC
DEF 14A · Proxy statementMay 6, 2024Meeting noticeSEC
4 · Change in ownershipApr 1, 2024Insider tradeSEC
144 · Notice of proposed saleMar 28, 2024Other filingsSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
4 · Change in ownershipFeb 23, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
10-Q · Quarterly reportFeb 7, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedJan 25, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 22, 2024Big-stake noticeSEC
4 · Change in ownershipJan 12, 2024Insider tradeSEC
4 · Change in ownershipJan 12, 2024Insider tradeSEC
10-K · Annual reportNov 27, 2023Annual reportSEC
10-Q · Quarterly reportAug 8, 2023Quarterly reportSEC
4 · Change in ownershipJun 30, 2023Insider tradeSEC
144 · Notice of proposed saleJun 28, 2023Other filingsSEC
8-K · Current reportMay 24, 2023Meeting outcomeSEC
10-Q · Quarterly reportMay 9, 2023Quarterly reportSEC
8-K · Current reportApr 14, 2023Current reportSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
DEFA14A · Additional proxy materialApr 4, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 4, 2023Meeting noticeSEC
8-K · Current reportMar 10, 2023Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 9, 2023Big-stake noticeSEC
8-K · Current reportFeb 7, 2023Current reportSEC
424B5 · ProspectusFeb 7, 2023Offer documentSEC
10-Q · Quarterly reportFeb 7, 2023Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedJan 31, 2023Big-stake noticeSEC
10-K/A · Annual report, amendedJan 27, 2023Annual reportSEC
8-K · Current reportDec 2, 2022Current reportSEC
10-K · Annual reportNov 28, 2022Annual reportSEC
UPLOAD · Letter from the SECAug 12, 2022Other filingsSEC
CORRESP · Letter to the SECAug 10, 2022Other filingsSEC
10-Q · Quarterly reportAug 9, 2022Quarterly reportSEC
UPLOAD · Letter from the SECJul 29, 2022Other filingsSEC
4 · Change in ownershipJun 29, 2022Insider tradeSEC
4 · Change in ownershipJun 29, 2022Insider tradeSEC
4 · Change in ownershipJun 29, 2022Insider tradeSEC
4 · Change in ownershipJun 29, 2022Insider tradeSEC
4 · Change in ownershipJun 29, 2022Insider tradeSEC
S-8 · Registration statement for employee plansJun 10, 2022Offer documentSEC
4 · Change in ownershipMay 27, 2022Insider tradeSEC
8-K · Current reportMay 27, 2022Meeting outcomeSEC
10-Q · Quarterly reportMay 10, 2022Quarterly reportSEC
DEFA14A · Additional proxy materialApr 11, 2022Meeting noticeSEC
DEF 14A · Proxy statementApr 11, 2022Meeting noticeSEC
8-K · Current reportApr 8, 2022Management or board changeSEC
8-K · Current reportMar 4, 2022Management or board changeSEC
SC 13G · Big-stake noticeFeb 9, 2022Big-stake noticeSEC
10-Q · Quarterly reportFeb 9, 2022Quarterly reportSEC
SC 13G · Big-stake noticeFeb 9, 2022Big-stake noticeSEC
8-K · Current reportFeb 4, 2022Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 2, 2022Big-stake noticeSEC
8-K · Current reportFeb 2, 2022Current reportSEC
10-K · Annual reportNov 24, 2021Annual reportSEC
8-K · Current reportSep 27, 2021Current reportSEC
S-3ASR · Registration statementSep 24, 2021Offer documentSEC
8-K · Current reportSep 13, 2021Current reportSEC
10-Q · Quarterly reportAug 12, 2021Quarterly reportSEC
4 · Change in ownershipAug 4, 2021Insider tradeSEC
4 · Change in ownershipAug 4, 2021Insider tradeSEC
4 · Change in ownershipAug 4, 2021Insider tradeSEC
4 · Change in ownershipAug 4, 2021Insider tradeSEC
4 · Change in ownershipAug 4, 2021Insider tradeSEC
4 · Change in ownershipAug 4, 2021Insider tradeSEC
4 · Change in ownershipAug 4, 2021Insider tradeSEC
4 · Change in ownershipJul 1, 2021Insider tradeSEC
4 · Change in ownershipJul 1, 2021Insider tradeSEC
8-K · Current reportJun 24, 2021Material contractSEC
424B5 · ProspectusJun 24, 2021Offer documentSEC
3 · Initial statement of ownershipJun 9, 2021Insider tradeSEC
8-K · Current reportMay 28, 2021Meeting outcomeSEC
4 · Change in ownershipMay 25, 2021Insider tradeSEC
4 · Change in ownershipMay 19, 2021Insider tradeSEC
10-Q · Quarterly reportMay 13, 2021Quarterly reportSEC
DEF 14A · Proxy statementApr 12, 2021Meeting noticeSEC
S-8 · Registration statement for employee plansApr 9, 2021Offer documentSEC
PRE 14A · Preliminary proxy statementApr 1, 2021Meeting noticeSEC
4 · Change in ownershipFeb 26, 2021Insider tradeSEC

This page holds 200 of 638 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Anavex Life Sciences Corp.’s releases · as of Aug 28, 2026

Common shares
92,696,842
Fully diluted
92,696,842

Fully diluted

LineSharesAs of
Common shares92,696,842Aug 28, 2026

Share count over time

CountShares
Aug 28, 202692,696,842

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
BlackRock8.14M8.8%US$16.5M+88,519Nov 13, 2026
Vanguard5.65M6.1%US$11.4M−4,939Nov 13, 2026
GMT Capital Corp2.7M2.9%US$5.46MNewNov 16, 2026
Federated Hermes, Inc.2.59M2.8%US$5.22M+1.51MNov 12, 2026
Two Sigma2.35M2.5%US$4.74M−698KNov 16, 2026
Geode Capital2.28M2.5%US$4.6M−132KNov 6, 2026
State Street1.96M2.1%US$3.96M+35,639Nov 12, 2026
Summit Financial, LLC889K0.96%US$1.8M−20,361Nov 12, 2026
Goldman Sachs889K0.96%US$1.8M−1,568Nov 16, 2026
Schwab887K0.96%US$1.79M+152KNov 16, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Barclays868K0.94%US$1.75M+114KNov 6, 2026
Northern Trust789K0.85%US$1.59M+4,796Nov 16, 2026
Marshall Wace, LLP758K0.82%US$1.53M−131KNov 13, 2026
Citadel549K0.59%US$1.11M+220KNov 16, 2026
Private Advisor Group, LLC432K0.47%US$873K−72,000Nov 10, 2026
UBS431K0.46%US$871K−190KNov 16, 2026
Morgan Stanley414K0.45%US$837K+219KNov 13, 2026
Bank of America405K0.44%US$818K−249KNov 16, 2026
LPL Financial LLC357K0.39%US$722K−48,889Nov 6, 2026
Stifel Financial Corp353K0.38%US$713K+20,378Nov 12, 2026
Wellington331K0.36%US$669KNewNov 16, 2026
BNY297K0.32%US$601K+9,238Nov 5, 2026
Nuveen226K0.24%US$457K+43,416Nov 10, 2026
Apella Capital, LLC223K0.24%US$341K−4,989Oct 8, 2026
AQR Capital Management LLC214K0.23%US$433K−749KNov 16, 2026
Susquehanna202K0.22%US$409K−117KNov 16, 2026
D. E. Shaw & Co., Inc.192K0.21%US$387K+76,176Nov 16, 2026
CPP Investments187K0.20%US$378K−14,500Nov 16, 2026
Pvg Asset Management Corp155K0.17%US$314K−172KOct 19, 2026
Los Angeles Capital Management LLC139K0.15%US$281K+42,015Nov 12, 2026
Invesco139K0.15%US$281K+28,965Nov 12, 2026
Voleon Capital Management LP137K0.15%US$276K+73,121Nov 16, 2026
AllianceBernstein136K0.15%US$275K−10,370Nov 16, 2026
JPMorgan130K0.14%US$307K+83,363Nov 12, 2026
Alps Advisors Inc122K0.13%US$246K+27,887Nov 2, 2026
Empowered Funds, LLC121K0.13%US$244KNewNov 13, 2026
Bridgeway Capital Management, LLC121K0.13%US$244K−2,062Nov 16, 2026
Rhumbline Advisers111K0.12%US$223K−1,503Nov 10, 2026
XTX Topco Ltd94,5070.10%US$191K+61,791Nov 16, 2026
HSBC93,9360.10%US$205K−8,989Nov 16, 2026
Hikari Power Ltd85,5850.09%US$173KNo changeOct 29, 2026
T. Rowe Price83,6660.09%US$170K+16,948Nov 16, 2026
Renaissance Technologies79,9990.09%US$162KNewNov 12, 2026
Point72 Asset Management, L.P.77,5020.08%US$157K−79,984Nov 16, 2026
PNC Financial Services Group, Inc.72,4010.08%US$146K+5,779Nov 6, 2026
DWS69,2910.07%US$140K−10,041Nov 6, 2026
Cerity Partners LLC67,1250.07%US$136K−21,231Nov 13, 2026
180 Wealth Advisors, LLC63,6900.07%US$129K−7,340Nov 3, 2026
LexAurum Advisors, LLC61,1350.07%US$123K−3,915Oct 19, 2026
Cetera Investment Advisers55,8450.06%US$113K−19,276Nov 13, 2026

This page holds 50 of 162 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund2.93M3.2%US$7.58M+194KJun 30, 2026
iShares Russell 2000 ETF2.42M2.6%US$6.26M+281KJun 30, 2026
Federated Hermes MDT Small Cap Core Fund2.05M2.2%US$5.62M+1.52MJul 31, 2026
Vanguard Extended Market Index Fund1.04M1.1%US$2.7M−3,747Jun 30, 2026
Fidelity Small Cap Index Fund1M1.1%US$2.76M+134KJul 31, 2026
iShares Russell 2000 Value ETF737K0.80%US$1.91MNewJun 30, 2026
iShares Biotechnology ETF632K0.68%US$1.64M−36,699Jun 30, 2026
Fidelity Extended Market Index Fund485K0.52%US$1.47M+31,997May 31, 2026
Vanguard Russell 2000 Index Fund450K0.49%US$1.36M+35,255May 31, 2026
Schwab U.S. Small-Cap ETF440K0.47%US$1.33M+22,298May 31, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
iShares Micro-Cap ETF310K0.33%US$803K+88,914Jun 30, 2026
Vanguard Health Care Index Fund266K0.29%US$806K+10,100May 31, 2026
Schwab Small-Cap Index Fund225K0.24%US$618K+32,279Jul 31, 2026
Master Small Cap Index Series187K0.20%US$483K+45,760Jun 30, 2026
Fidelity Total Market Index Fund176K0.19%US$533K+19,687May 31, 2026
iShares U.S. Small-Cap Equity Factor ETF162K0.17%US$444K−126KJul 31, 2026
iShares Russell 2000 Growth ETF143K0.15%US$370K−581KJun 30, 2026
Fidelity Series Total Market Index Fund140K0.15%US$425K+15,660May 31, 2026
iShares Core S&P Total U.S. Stock Market ETF123K0.13%US$319K+2,992Jun 30, 2026
Ultra-Small Company Market Fund123K0.13%US$319KNewJun 30, 2026
Nuveen Small Cap Blend Index Fund122K0.13%US$336K+13,566Jul 31, 2026
Fidelity Small Cap Value Index Fund108K0.12%US$279KNewJun 30, 2026
EQ/2000 Managed Volatility Portfolio101K0.11%US$261K+3,499Jun 30, 2026
ALPS Medical Breakthroughs ETF95,5220.10%US$289K+15,887May 31, 2026
Vanguard Russell 2000 Growth Index Fund81,6990.09%US$248K+5,350May 31, 2026
Schwab U.S. Broad Market ETF68,9200.07%US$209KNewMay 31, 2026
Small Company Growth Portfolio61,6790.07%US$160KNewJun 30, 2026
EQ/Small Company Index Portfolio61,4700.07%US$159K+15,550Jun 30, 2026
LVIP State Street Small-Cap Index Fund58,7000.06%US$152KNo changeJun 30, 2026
Invesco RAFI US 1500 Small-Mid ETF56,9230.06%US$157K+30,446Jul 31, 2026
EQ/AB Small Cap Growth Portfolio53,5700.06%US$139K+15,550Jun 30, 2026
Fidelity Nasdaq Composite Index Fund53,5390.06%US$162KNo changeMay 31, 2026
Fidelity ZERO Total Market Index Fund49,3610.05%US$136K+5,019Jul 31, 2026
Vanguard Balanced Index Fund48,9760.05%US$127KNo changeJun 30, 2026
Small Cap Index Fund48,2890.05%US$125K+4,889Jun 30, 2026
Nuveen Equity Index Fund46,0810.05%US$127KNo changeJul 31, 2026
Global X Russell 2000 ETF44,0510.05%US$121K+7,381Jul 31, 2026
Vanguard Institutional Total Stock Market Index Fund38,6600.04%US$100KNo changeJun 30, 2026
Small Cap Index Fund38,1630.04%US$116K+5,654May 31, 2026
Fidelity ZERO Extended Market Index Fund33,2570.04%US$91,457+602Jul 31, 2026
MetLife Russell 2000 Index Portfolio31,2710.03%US$80,992+14,313Jun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio29,9000.03%US$77,441No changeJun 30, 2026
ATM Small Cap Managed Volatility Portfolio26,1530.03%US$67,736No changeJun 30, 2026
EQ/Common Stock Index Portfolio23,9000.03%US$61,901No changeJun 30, 2026
NVIT Small Cap Index Fund22,3860.02%US$57,980+5,338Jun 30, 2026
Small-Cap Index Portfolio22,3570.02%US$57,905No changeJun 30, 2026
U.S. Core Equity 2 Portfolio21,3970.02%US$58,842No changeJul 31, 2026
1290 VT Micro Cap Portfolio20,9310.02%US$54,211+5,240Jun 30, 2026
Small Cap Index Trust20,4410.02%US$52,942+4,404Jun 30, 2026
Blackstone Alternative Multi-Strategy Fund19,7000.02%US$51,023−600Jun 30, 2026

This page holds 50 of 111 holders. Open Shareholders

Big stakes

HolderStakeSharesDate
Vanguard Capital Management LLC5.03%4.66MJun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
George F Tidmarsh
Other companies: Revelation Biosciences, Inc. (Director · Jan 10, 2022 – Feb 11, 2025 · Past); La Jolla Pharmaceutical Co (President, CEO & Secretary, Director · Jan 19, 2012 – Apr 15, 2019 · Past); Spectrum Pharmaceuticals Inc (CSO and Head of R&D Operations · Jul 15, 2010 – Jan 3, 2011 · Past)
Executive Director, Director · Oct 10, 2011 – Feb 9, 2012 · Past
Cameron Durrant
Other companies: Humanigen Inc (Chief Executive Officer, Director · Jan 7, 2016 – Jul 27, 2022 · Past); Immune Pharmaceuticals Inc (Director · Jul 10, 2014 – Jan 25, 2017 · Past)
Executive Chairman, Director · Dec 17, 2007 – Feb 3, 2011 · Past
Harvey Lalach
Other companies: Fulucai Productions Ltd (CFO, Director · Jul 2, 2015 – Jul 2, 2015 · Past)
President COO Secretary, Director · Apr 25, 2006 – May 24, 2012 · Past
Sandra Boenisch
Other companies: Destiny Media Technologies Inc. (Chief Financial Officer · Dec 13, 2017 – Oct 3, 2019 · Past)
Principal Financial Officer · Since at least Oct 1, 2015
Alexandre VamvakidesChief Scientific Officer, Director · Jan 31, 2007 – Jan 31, 2007 · Past
Alison E AyersDirector · May 20, 2008 – Jun 29, 2010 · Past
Angela VernadakiVP Business Development · Feb 7, 2007 – Feb 8, 2007 · Past
Athanasios SkarpelosDirector · Oct 1, 2013 – Mar 31, 2025 · Past
Axel PaegerIndependent Director · Since at least Feb 23, 2026
Bernd MetznerDirector · May 7, 2014 – Sep 22, 2016 · Past
All 22 people
PersonSeat
Christopher U MisslingPresident and CEO, Director · Since at least Jul 5, 2013
Claus van der VeldenIndependent Director · Since at least Mar 2, 2018
Daniel KlamerVice President of Business Development and Scientific Strategy · Since at least Nov 5, 2026
Elliot FavusDirector · May 7, 2014 – May 21, 2021 · Past
Herve De KergrohenCEO · Jun 12, 2009 – Jun 12, 2009 · Past
Pei Ru WuCOO, Director · Apr 25, 2006 – Apr 25, 2006 · Past
Peter DonhauserMember of the Board of Directors · Since at least Feb 8, 2017
Steffen ThomasDirector · Since at least Oct 1, 2018
Terrie KellmeyerDirector, President, and Chief Executive Officer · Since at least May 4, 2026
William Sean LowryDirector · Feb 24, 2011 – Feb 24, 2011 · Past
Wolfgang LiedtkeSenior Vice President, Global Head of Neurology · Since at least Jan 8, 2026
Yang WuPresident & CEO, Director · Apr 25, 2006 – Apr 25, 2006 · Past

Open People

Log in to ask 6ix AI your own questions about Anavex Life Sciences Corp.